Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 154Terminated 31Unknown 24Withdrawn 16Recruiting 11Active not recruiting 10Not yet recruiting 3Suspended 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Neoplasm, Residual 1Myelodysplastic Syndromes 1Multiple Myeloma 1Hematologic Neoplasms 1

Interventions

daratumumab 2Dexamethasone 2vactosertib 1selinexor 1pomalidomide 1mirdametinib 1fludarabine phosphate 1carfilzomib 1aldesleukin 1Specimen Handling 1Sirolimus 1Melphalan 1Lenalidomide 1Interleukin-2 1IL32 protein, human 1Cyclophosphamide 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Multiple Myeloma × Melphalan × Clear all
NCT00892346 2016-05-10

Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma

Shanghai Jiao Tong University School of Medicine

Phase 3 Suspended
80 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡